Third COVID-19 jab benefits people with MS
- PMID: 35121858
- PMCID: PMC8815017
- DOI: 10.1038/s41582-022-00625-w
Third COVID-19 jab benefits people with MS
Comment on
-
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination.JAMA Neurol. 2022 Mar 1;79(3):307-309. doi: 10.1001/jamaneurol.2021.5109. JAMA Neurol. 2022. PMID: 35072702 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
